The Regulatory Subunit PPP2R2A of PP2A Enhances Th1 and Th17 Differentiation through Activation of the GEF-H1/RhoA/ROCK Signaling Pathway
Open Access
- 24 March 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 206 (8) , 1719-1728
Abstract
Protein phosphatase 2A (PP2A) composed of a scaffold subunit, a catalytic subunit, and multiple regulatory subunits is a ubiquitously expressed serine/threonine phosphatase. We have previously shown that the PP2A catalytic subunit is increased in T cells from patients with systemic lupus erythematosus and promotes IL-17 production by enhancing the activity of Rho-associated kinase (ROCK) in T cells. However, the molecular mechanism whereby PP2A regulates ROCK activity is unknown. In this study, we show that the PP2A regulatory subunit PPP2R2A is increased in T cells from people with systemic lupus erythematosus and binds to, dephosphorylates, and activates the guanine nucleotide exchange factor GEF-H1 at Ser885, which in turn increases the levels of RhoA-GTP and the activity of ROCK in T cells. Genetic PPP2R2A deficiency in murine T cells reduced Th1 and Th17, but not regulatory T cell differentiation and mice with T cell–specific PPP2R2A deficiency displayed less autoimmunity when immunized with myelin oligodendrocyte glycoprotein peptide. Our studies indicate that PPP2R2A is the regulatory subunit that dictates the PP2A-directed enhanced Th1 and Th17 differentiation, and therefore, it represents a therapeutic target for pathologies linked to Th1 and Th17 cell expansion.Keywords
Funding Information
- Foundation for the National Institutes of Health (RO1 AI136924)
This publication has 42 references indexed in Scilit:
- Inhibition of ROCK activity regulates the balance of Th1, Th17 and Treg cells in myasthenia gravisClinical Immunology, 2019
- IL-17 in Chronic Inflammation: From Discovery to TargetingTrends in Molecular Medicine, 2016
- T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunityJournal of Clinical Investigation, 2015
- Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanismProceedings of the National Academy of Sciences, 2014
- Enhanced Rho‐Associated Protein Kinase Activation in Patients With Systemic Lupus ErythematosusArthritis & Rheumatism, 2013
- Taming lupus—a new understanding of pathogenesis is leading to clinical advancesNature Medicine, 2012
- Systemic Lupus ErythematosusNew England Journal of Medicine, 2011
- Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in miceJournal of Clinical Investigation, 2010
- Rho family GTPases and their regulators in lymphocytesNature Reviews Immunology, 2009
- ROCKs: multifunctional kinases in cell behaviourNature Reviews Molecular Cell Biology, 2003